Aztreonam lysine

This classification denotes a beta-lactam antibiotic with the molecular formula C13H17N5O8S2.C6H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XNM7LT65NP. European Medicines Agency schedules aztreonam lysine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30777. The term aztreonam lysine is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule aztreonam lysine under HS 29419000 and SITC 54139. As of Q4 2014, AZTREONAM LYSINE remains US FDA's Preferred Term for this commodity. Aztreonam lysine bears US NLM identifiers UMLS ID C2698293 and NCI Concept Code C76021. SMILES: C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2CSC(N2)N.C(CCN)C[C@@H](C(=O)O)N.